Vergoeding 2019-2023 voor ATC-subgroep L04AF : Jak-remmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L04AF01 Tofacitinib | 9.498.404 | 10.730.509 | 11.569.330 | 9.521.543 | 8.892.883 |
| L04AF02 Baricitinib | 6.317.303 | 8.141.555 | 10.332.475 | 10.451.911 | 9.169.267 |
| L04AF03 Upadacitinib | . | 303.547 | 2.860.013 | 7.916.575 | 10.316.861 |
| L04AF04 Filgotinib | . | 3.079 | 1.114.195 | 4.227.198 | 5.804.499 |
| Totaal | 15.815.707 | 19.178.690 | 25.876.013 | 32.117.227 | 34.183.511 |